Mixed oral candidiasis in type 2 diabetic patients: Identification and spectrum of sensitivity
Abstract
Introduction. Patients with type 2 diabetes mellitus are susceptible to acquire Candida spp. infections, sometimes involving more than one species. The resistance of some species to antimycotic agents can cause treatment failure.
Objectives. To determine the frequency and clinical varieties of mixed oral candidiasis in patients with type 2 diabetes mellitus, the involved species, and its sensitivity spectra when exposed to antifungals used as candidiasis treatment.
Material and methods. We developed an analytical cross-sectional study with 72 patients with type 2 diabetes mellitus with hyperglycemia (HbA1C ≥ 7%) and an oral candidiasis diagnosis. The causal species of oral candidiasis were identified through microbiological techniques, and sensitivity tests were carried out using the diffusion method in a plate with strips (E-test ®).
Results. We included 72 patients in the study, 32 (44%) males and 40 (56%) females. Patients were divided into three age groups: young adults (17%), adults (74%), and older adults (9%). The mean age of the patients was 51 years. No significant differences were found between mixed oral candidiasis and groups (sex and age), or between mixed oral candidiasis and gender, glycosylated hemoglobin level (HbA1C), antihyperglycemic treatment, or type 2 diabetes mellitus time of diagnosis. We found a correlation between the adult group and development of mixed or simple oral candidiasis. The results showed eight (13%) cases of mixed oral candidiasis: seven with a coinfection of two species and one with a coinfection of three species. The identified species were Candida albicans, C. glabrata, C. dubliniensis, C. kefyr, C. tropicalis, and C. krusei. Most of these species presented sensitivity against ketoconazole and fluconazole, and higher resistance to itraconazole.
Conclusions. Mixed oral candidiasis occurs in approximately 10% of the patients with type 2 diabetes mellitus and its treatment can be ineffective when the etiological agent is not identified.
Downloads
References
Centers for Disease Control and Prevention. National diabetes statistics report: Estimates of diabetes and its burned in the United States. Atlanta, GA: US Department of Health and Human Services. Fecha de consulta: 14 de agosto de 2017. Disponible en: https://www.cdc.gov/diabetes/data/statistics-report/index.html
Bijelic R, Balaban J, Milicevic S, Sipka SU. The association of obesity and microvascular complications with glycemic control in patients with type 2 diabetes mellitus. Med Arch. 2020;74:14-8. https://doi.org/10.5455/medarh.2020.74.14
Instituto Nacional de Estadística y Geografía. Estadística a propósito del día mundial de la diabetes (14 de noviembre). Fecha de consulta: 10 de enero de 2023. Disponible en: https://www.inegi.org.mx/contenidos/saladeprensa/aproposito/2022/EAP_DIABETES2022.pdf
American Diabetes Association. Summary of Revisions: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2019;42(Suppl1.):S4-6. https://doi.org/10.2337/dc19-Srev01
Savić S. Diabetes mellitus. En: Tešanović G, editor. Porodična medicina. Banja Luka: Medicinski fakultet u Banjoj Luci; 2014. p. 319-41.
Polsky S, Ellis SL. Obesity, insulin resistance, and type 1 diabetes mellitus. Curr Opin Endocrinol Diabetes Obes. 2015;22:277-82. https://doi.org/10.1097/MED.0000000000000170
Mediavilla-Bravo JJ. Complicaciones de la diabetes mellitus. Diagnóstico y tratamiento. Semergen: 2001;27:132-45. https://doi.org/10.1016/S1138-3593(01)73931-7
Lamey PJ, Darwaza A, Fisher BM, Samaranayake LP, Macfarlane TW, Frier BM. Secretor status, candidal carriage and candidal infection in patients with diabetes mellitus. J Oral Pathol. 1988;17:354-7. https://doi.org/10.1111/j.1600-0714.1988.tb01549.x
McIntyre GT. Oral candidiasis. Dent Update. 2001;28:132-9. https://doi.org/10.12968/denu.2001.28.3.132
Shoham S, Levitz SM. The immune response to fungal infections. Br J Haematol. 2005;129:569-82. https://doi.org/10.1111/j.1365-2141.2005.05397.x
Bonifaz A. Micología médica básica. 6a edición. México: McGraw-Hill, 2012. p. 445-84.
Suárez BL, Álvarez MI, de Bernal M, Collazos A. Candida species and other yeasts in the oral cavities of type 2 diabetic patients in Cali, Colombia. Colomb Med. 2013;44:26-30.
Mohammadi F, Javaheri MR, Nekoeian S, Dehghan P. Identification of Candida species in the oral cavity of diabetic patients. Curr Med Mycol. 2016;2:1-7. https://doi.org/10.18869/acadpub.cmm.2.2.4
Manfredi M, McCullough MJ, Polonelli L, Conti S, Al-Karaawi ZM, Vescovi P, et al. In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. Oral Microbiol Immunol. 2006;21:177-82. https://doi.org/10.1111/j.1399-302X.2006.00274.x
Bremenkamp RM, Caris AR, Jorge AO, Back-Brito GN, Mota AJ, Balducci I, et al. Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. Arch Oral Biol. 2011;56:549-55. https://doi.org/10.1016/j.archoralbio.2010.11.018
Manzano-Gayosso P, Méndez-Tovar LJ, Hernández-Hernández F, López-Martínez R. La resistencia a los antifúngicos: un problema emergente en México. Gac Med Mex. 2008;144:23-6.
Romero-Luévano AG, Araiza-Santibáñez J, Hernández MA, Cerón-Araiza M, Hernández-Guzmán VA, Ponce RM, et al. Candidosis mixtas en aislamientos clínicos de pacientes procedentes del Hospital General de México Dr. Eduardo Liceaga; identificación e importancia. Dermatol Rev Mex. 2014;58:239-46.
Pfaller MA, Boyken L, Messer SA, Tendolkar S, Hollis RJ, Diekema DJ. Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. J Clin Microbiol. 2004;42:4977-9. https://doi.org/10.1128/JCM.42.11.4977-4979.2004
Hernández-Solís SE, Rueda-Gordillo F, Rojas-Herrera RA. Actividad de la proteinasa en cepas de Candida albicans aisladas de la cavidad oral de pacientes inmunodeprimidos, con candidiasis oral y sujetos sanos. Rev Iberoam Micol. 2014;31:13740. https://doi.org/10.1016/j.riam.2013.09.003
Carda C, Mosquera-Lloreda N, Salom L, Gómez de Ferraris ME, Peydró A. Structural and functional salivary disorders in type 2 diabetic patients. Med Oral Patol Oral Cir Bucal. 2006;11:E309-14.
Aguirre--Urizar JM. Candidiasis orales. Rev Iberoam Micol. 2002;19:17-21.
Osuna M, Rivera MC, Bocanegra C, Lancheros A, Tovar H, Hernández JI, et al. Caracterización de la diabetes mellitus tipo 2 y el control metabólico en el paciente hospitalizado. Acta Med Colomb. 2014;39:344-51.
Fanello S, Bouchara JP, Sauteron M, Delbos V, Parot E, Marot-Leblond A, et al. Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients. J Med Microbiol. 2006;55:223-8. https://doi.org/10.1099/jmm.0.46155-0
Balan P, B Gogineni S, Kumari N S, Shetty V, Lakshman Rangare A, L Castelino R, et al. Candida carriage rate and growth characteristics of saliva in diabetes mellitus patients: A case-control study. J Dent Res Dent Clin Dent Prospects. 2015;9:274-9. https://doi.org/10.15171/joddd.2015.048
Rodrigues CF, Rodrigues ME, Henriques M. Candida sp. infections in patients with diabetes mellitus. J Clin Med. 2019;10:8:76. https://doi.org/10.3390/jcm8010076
de la Rosa-García E, Miramontes-Zapata M, Sánchez-Vargas LO, Mondragón-Padilla A. Oral colonisation and infection by Candida sp. in diabetic and non-diabetic patients with chronic kidney disease on dialysis. Nefrologia. 2013;33:764-70. https://doi.org/10.3265/Nefrologia.pre2013.Aug.11790
Zuza-Alves DL, Silva-Rocha WP, Chaves GM. An update on Candida tropicalis based on basic and clinical approaches. Front Microbiol. 2017;8:1927. https://doi.org/10.3389/fmicb.2017.01927
Reyes-Montes MDR, Duarte-Escalante E, Martínez-Herrera E, AcostaAltamirano G, Frías-De León MG. Current status of the etiology of candidiasis in Mexico. Rev Iberoam Micol. 2017;34:203-10. https://doi.org/10.1016/j.riam.2017.05.001
Sanitá PV, Mima EG, Pavarina AC, Jorge JH, Machado AL, Vergani CE. Susceptibility profile of a Brazilian yeast stock collection of Candida species isolated from subjects with Candida associated denture stomatitis with or without diabetes. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:562-9. https://doi.org/10.1016/j.oooo.2013.07.002
Martínez MG, Perurena LM, Núñez CJ, Fernández AC, Bandera TF. Aislamiento, identificación y tipificación de levaduras en pacientes VIH positivos con candidiasis oral. Rev Cubana Med Trop. 1997;49:174-80.
Akpan A, Morgan R. Oral candidiasis. Postgrad Med J. 2002;78:455-9. https://doi.org/10.1136/pmj.78.922.455
Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidiasis. Diabet Med. 2006;23:455-9. https://doi.org/10.1111/j.1464-5491.2005.01701.x
Negri M, Henriques M, Svidzinski TI, Paula CR, Oliveira R. Correlation between Etest, disk diffusion, and microdilution methods for antifungal susceptibility testing of Candida species from infection and colonization. J Clin Lab Anal. 2009;23:324-30. https://doi.org/10.1002/jcla.20337
Pérez-Cárdenas JE, Hoyos AM, Cárdenas-Henao C. Sensibilidad antimicótica de diferentes especies de hongos aislados de pacientes con micosis ungueal en la ciudad de Manizales (Caldas, Colombia). Biosalud. 2012;11:26-39.
Manzano-Gayosso P, Méndez-Tovar LJ, Arenas R, Hernández-Hernández F, Millán-Chiu B, Torres-Rodríguez JM, et al. Levaduras causantes de onicomicosis en cuatro centros dermatológicos mexicanos y su sensibilidad antifúngica a compuestos azólicos. Rev Iberoam Micol. 2011;28:32-5. https://doi.org/10.1016/j.riam.2010.11.002
Lindberg E, Hammarström H, Ataollahy N, Kondori N. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Sci Rep. 2019;9:3838. https://doi.org/10.1038/s41598-019-40280-8
Song YB, Suh MK, Ha GY, Kim H. Antifungal susceptibility testing with Etest for Candida species isolated from patients with oral candidiasis. Ann Dermatol. 2015;27:715-20. https://doi.org/10.5021/ad.2015.27.6.715
Some similar items:
- Husein Husein-El Ahmed, Guillermo Arturo Cañadas-De la Fuente, Rafael Fernández-Castillo, Emilio González-Jiménez, Jesús Cantero-Hinojosa, Marita Lardón-Fernández, Generalized cutaneous candidiasis in newborn at term , Biomedica: Vol. 32 No. 2 (2012)
- Catalina de Bedout, Julio Ayabaca, Ricardo Vega, Matilde Méndez, Axel R. Santiago, María Lucrecia Pabón, Angela Tabares, Myrtha Arango, Angela Restrepo, Vance Newell, Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method. , Biomedica: Vol. 23 No. 1 (2003)
- Soraya Morales-López, Keiner Ustate, Zulay Pedrozo, Yulibeth Torres, Biochemical typing and evaluation of pathogenicity in vulvovaginal isolates of Candida albicans complex , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Liliana Torcoroma García, Liany Johanna Luna, Tania Katherine Velasco, Beatriz Elena Guerra, new multiplex PCR for species-specific diagnosis of human candidiasis , Biomedica: Vol. 37 No. 2 (2017)
- Ana Elisa Rojas, Jorge Enrique Pérez, Johan Sebastián Hernández, Yuliana Zapata, Quantitative analysis of the expression of fluconazole-resistant genes in strains of Candida albicans isolated from elderly people at their admission in an intensive care unit in Manizales, Colombia , Biomedica: Vol. 40 No. 1 (2020)
- Jorge Alberto Cortés, José Franklin Ruiz, Lizeth Natalia Melgarejo-Moreno, Elkin V. Lemos, Candidemia in Colombia , Biomedica: Vol. 40 No. 1 (2020)
- Martha Puello, Gregorio Young, Paola Suárez, Phospholipase and proteinase activities of isolates of colonizing Candida spp. causing vulvovaginitis in pregnant women , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
Copyright (c) 2023 Biomedica
This work is licensed under a Creative Commons Attribution 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
